Element Biosciences, Inc. announced that it has received $276.999999 million in funding from Wellington Management Group LLP, Samsung Electronics Co., Ltd., Fidelity Management & Research Company LLC, Foresite Capital Management, LLC, T. Rowe Price Group, Inc., VR Adviser, LLC, and other investors

On July 11, 2024, Element Biosciences, Inc. closed the transaction and received 276,999,999 in a round round of funding led by new investor Wellington Management Group LLP . The transaction included participation from new investor Samsung Electronics Co., Ltd., returning investors Fidelity Management & Research Company LLC, Foresite Capital Management, LLC, funds and accounts advised by T. Rowe Price Group, Inc., VR Adviser, LLC, and others. The company has received over $680,000,000 in funding till date.

The round has been raised at a post-money valuation of $1,030,000,000.